Global, regional, and national burden of tuberculosis and multidrug-resistant tuberculosis by HIV status, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023

By afschroeder • July 2, 2026

GBD 2023 TB HIV Collaborators. Global, regional, and national burden of tuberculosis and multidrug-resistant tuberculosis by HIV status, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet Infect Dis. 2026 Jul 1:S1473-3099(26)00295-1. doi: 10.1016/S1473-3099(26)00295-1. Epub ahead of print. PMID: 42385762.

Tags: Infectious Diseases, Publications, Veterans Administration

Cefepime resistance with preserved ceftriaxone susceptibility in Proteus mirabilis osteomyelitis associated with bla OXA-1 gene amplification: Two case reports with genomic analysis

Lima A, Collins M, Jaramillo M, Gonzalez-Ferrer S, Sircar A, Allyn PR, Yang S. Cefepime resistance with preserved ceftriaxone susceptibility in Proteus mirabilis osteomyelitis associated with blaOXA-1 gene amplification:[...]

Enabled self-care for HIV infection: an inflection point for sustainable epidemic control

Joseph Davey D. Enabled self-care for HIV infection: an inflection point for sustainable epidemic control. Lancet Glob Health. 2027 Apr 14:103970. doi: 10.1016/j.langlo.2026.103970. Epub ahead[...]

Impact on daptomycin resistance using combination of daptomycin plus ceftaroline in daptomycin-susceptible and -resistant Staphylococcus aureus

Mishra NN, Black CA, Abdelhady W, Farah S, Rodas NA, Brizuela J, Lopez CB, Artaza JN, Sakoulas G, Rose WE. Impact on daptomycin resistance using[...]